Triethylene Glycol

Triethylene Glycol

SCHEMBL5144067

CCCCCCCCc1ccccc1Oc1ccccc1CCCCCCCC.OCCOCCOCCO

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
USP2 O75604 1/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPK1 P28482 1/20 0.52
CASP1 P29466 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
SLCO1B3 Q9NPD5 1/20 0.52
SLCO1B1 Q9Y6L6 1/20 0.52
THRB P10828 2/20 0.50
THRA P10827 1/20 0.50
HTT P42858 1/20 0.50
MAPT P10636 1/20 0.50
LIPG Q9Y5X9 1/20 0.47
ALOX5 P09917 1/20 0.47
PTGS2 P35354 1/20 0.47
PPARA Q07869 2/20 0.45
PPARG P37231 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetraethylene Glycol SCHEMBL5145447 1.00 MEN1 (0.52) MEN1KMT2AUSP2ALDH1A1LMNA
Triethylene Glycol SCHEMBL5142014 1.00 MEN1 (0.52) MEN1KMT2AUSP2ALDH1A1LMNA
Triethylene Glycol SCHEMBL11002434 1.00 MEN1 (0.52) MEN1KMT2AUSP2ALDH1A1LMNA
Tetraethylene Glycol SCHEMBL5143759 1.00 MEN1 (0.52) MEN1KMT2AUSP2ALDH1A1LMNA
Di(Hydroxyethyl)Ether SCHEMBL5144100 0.98 THRB (0.51) MEN1KMT2AUSP2ALDH1A1LMNA
Di(Hydroxyethyl)Ether SCHEMBL7263984 0.98 THRB (0.51) MEN1KMT2AUSP2ALDH1A1LMNA
Di(Hydroxyethyl)Ether SCHEMBL5144171 0.98 THRB (0.51) MEN1KMT2AUSP2ALDH1A1LMNA
Triethylene Glycol SCHEMBL5143985 0.94 MEN1 (0.44) MEN1KMT2AUSP2ALDH1A1LMNA
Tetraethylene Glycol SCHEMBL5143708 0.94 MEN1 (0.44) MEN1KMT2AUSP2ALDH1A1LMNA
Di(Hydroxyethyl)Ether SCHEMBL5145485 0.92 TSHR (0.46) MEN1KMT2AUSP2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3770154-B1 GLYCOLIDE PRODUCTION METHOD KUREHA CORP (JP) 2025-02-19 EP disclosed
US-20240182397-A1 METHOD FOR PRODUCING GLYCOLIDE KUREHA CORPORATION (JP) 2024-06-06 US disclosed
EP-4310078-A1 METHOD FOR PRODUCING GLYCOLIDE Kureha Corporation (JP) 2024-01-24 EP disclosed
CN-116897151-A Process for producing glycolide 株式会社吴羽 2023-10-17 CN disclosed
US-11753391-B2 Method for producing glycolide KUREHA CORPORATION (JP) 2023-09-12 US disclosed
CN-111741952-B Process for producing glycolide 株式会社吴羽 2023-06-09 CN disclosed
EP-3770153-B1 METHOD FOR PRODUCING GLYCOLIDE KUREHA CORP (JP) 2022-12-28 EP disclosed
WO-2022196178-A1 METHOD FOR PRODUCING GLYCOLIDE 株式会社クレハ 2022-09-22 WO disclosed
US-11078179-B2 Method for producing cyclic ester KUREHA CORPORATION (JP) 2021-08-03 US disclosed
US-11046665-B2 Method for producing α-hydroxycarboxylic acid dimeric cyclic ester KUREHA CORPORATION (JP) 2021-06-29 US disclosed
US-7235673-B2 Glycolide production process, and glycolic acid oligomer for glycolide production KUREHA CORPORATION (JP) 2007-06-26 US disclosed
EP-1366037-B1 GLYCOLIDE PRODUCTION PROCESS, AND GLYCOLIC ACID COMPOSITION KUREHA CHEMICAL IND CO LTD (JP) 2005-08-24 EP disclosed
US-6891048-B2 Glycolide production process, and glycolic acid composition KUREHA KAGAKU KOGYO KK (JP) 2005-05-10 US disclosed
EP-1377566-B1 GLYCOLIDE PRODUCTION PROCESS, AND GLYCOLIC ACID OLIGOMER FOR GLYCOLIDE PRODUCTION KUREHA CHEMICAL IND CO LTD (JP) 2004-09-22 EP disclosed
US-20040122240-A1 Glycolide production process, and glycolic acid oligomer for glycolide production KUREHA CORPORATION (JP) 2004-06-24 US disclosed
US-20040087805-A1 Glycolide production process, and glycolic acid composition KUREHA CORPORATION (JP) 2004-05-06 US disclosed
EP-1377566-A1 GLYCOLIDE PRODUCTION PROCESS, AND GLYCOLIC ACID OLIGOMER FOR GLYCOLIDE PRODUCTION Kureha Chemical Industry Co., Ltd. (JP) 2004-01-07 EP disclosed
EP-1366037-A2 GLYCOLIDE PRODUCTION PROCESS, AND GLYCOLIC ACID COMPOSITION KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2003-12-03 EP disclosed
WO-2002083661-A1 GLYCOLIDE PRODUCTION PROCESS, AND GLYCOLIC ACID OLIGOMER FOR GLYCOLIDE PRODUCTION KUREHA CHEMICAL INDUSTRY COMPANY, LIMITED (JP) 2002-10-24 WO disclosed
WO-2002070508-A2 GLYCOLIDE PRODUCTION PROCESS, AND GLYCOLIC ACID COMPOSITION KUREHA KAGAKU KOGYO K.K. (JP) 2002-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087805-A1 Glycolide production process, and glycolic acid composition DDOST, DAD1, AGL MEN1 4085/4885KMT2A 4398/4885USP2 1918/4885
US-11078179-B2 Method for producing cyclic ester SCD, DECR2, PDIA4 MEN1 3721/4885KMT2A 3681/4885USP2 2075/4885
US-20040122240-A1 Glycolide production process, and glycolic acid oligomer for glycolide production UGCG, DAD1, DDOST MEN1 4170/4885KMT2A 4761/4885USP2 2111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.